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Leishmania  donovani is a protozoal pathogen that 
belongs to the kinetoplastida order. Unlike in other 
eucaryotic systems, the first three enzymes of the de 
novo pyrimidine biosynthetic pathway are not  compo- 
nents of a multifunctional protein system. The three 
enzyme activities in the crude extract  were separated 
on  a Sephacryl S-200 column. 
Aspartate carbamoyltransferase (EC 2.1.3.2) has 
been purified to apparent homogeniety. The enzyme 
has an approximate molecular weight of 135,000 and 
seems to be  a tetramer of equivalent subunits of molec- 
ular weight 35,000. The enzyme shows strictly hyper- 
bolic kinetics  with both the substrates under  a variety 
of conditions and is not inhibited by nucleotide phos- 
phates. K,,, for carbamyl phosphate is 3.1 X M and 
for aspartate is 7.6 X M. Apparently, the enzyme 
has no regulatory role in pyrimidine biosynthesis. 
N-(Phosphonoacety1)-L-aspartic acid is a powerful 
competitive inhibitor (Ki  = 5 X M) for this enzyme 
with carbamyl phosphate as substrate. This inhibitor 
completely inhibits the growth of the vector form of 
organism at 60 WM and significantly  affects the growth 
of the pathogenic form in a  macrophage assay system, 
The potency of the inhibitor is comparable with allo- 
purinol which is undergoing human clinical trial as an 
antileishmanial drug. 
The enzymatic and genomic organization of pyrimidine 
biosynthetic pathway in eucaryotes presents some unusual 
features of considerable interest for comparative biochemistry 
and molecular biology (1). The six  enzyme activities required 
for the de novo biosynthesis of the  pyrimidine  ring  are  discrete 
proteins in  procaryotic  systems. In  contrast,  in higher  eucary- 
otes,  some of these enzyme activities  are expressed in a  single 
polypeptide chain.  In  mammals, as well as  in Drosophila, the 
first  three enzymes of the  pathway, namely carbamoyl-phos- 
phate  synthetase  (ammonia)  (EC 6.3.4.16), aspartate  carba- 
moyltransferase (EC 2.1.3.2), and  dihydroorotase  (EC 3.5.2.3) 
are encoded by a  single structural gene that produced  a  single 
polypeptide of trimeric  quarternary  structure  with  all  three 
enzymatic  activities (1-3). The  yeast  and  the Neurospora also 
express a  multienzymic protein,  but  this  has  activity for  only 
the  first two enzymes of the  pathway (4). Dihydroorotase  is a 
discreet enzyme for  these organisms. The  situation  in  other 
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types of lower eucaryotes that include the unicellular proto- 
zoal systems  remains essentially  unexplored. 
Leishmania  donouani is  an  important member of the  kine- 
toplastida group of protozoal parasites.  The organism has a 
digenic life cycle; a  flagellated promastigote form in the 
sandfly  vector and a  nonflagellated amastigote or pathogenic 
form in macrophage systems of hosts. The organism is  the 
causative  agent for kala  azar, a lethal form of visceral  leish- 
maniasis, that is widely prevalent  in  many  parts of the  tropical 
world (5 ,  6). The kinetoplastida, including L. donouani, are 
unable to synthesize purine de nouo and depend for their 
purine  requirement  on preformed purines of the  host  and  its 
own salvage pathway (7, 8). In contrast, the kinetoplastida 
appears  to have the enzymatic machinery necessary to  syn- 
thesize pyrimidine de nouo. All six enzymes of the pyrimidine 
pathway have  been detected  in  the promastigote  form of L. 
mexicana, in  the  trypromastigote form of Trypanosoma brucei 
and  in  the  culture form and  amastigote form of T. cruzi (9- 
11). Isotopic studies with L. donouani promastigotes  indicate 
the  presence of both  the de nouo and  the salvage pathway  in 
this organism (12). However, apart from these  initial works, 
very few systematic  studies have been  reported  on  the  char- 
acterization of the individual  enzymes of the pyrimidine path- 
way in kinetoplastida.  Important  questions of possible exist- 
ence of multifunctional single polypeptide enzyme systems, 
enzymatic regulatory sites, and potential chemotherapeutic 
sites etc. all  remain unexplored at the moment. In  this paper, 
we report  that,  in  the  cultural or the promastigote form of 
Leishmania  donouani, the  first  three enzymes of the  pyrimi- 
dine  biosynthetic  pathway  remain  as  three discrete proteins 
with separable enzyme activities. Further, extensive purifi- 
cation and characterization of aspartate transcarbamylase 
show that  unlike in many  bacterial  systems,  this enzyme  does 
not have any obvious regulatory role in this biosynthetic 
pathway. Finally, N-(phosphonoacety1)-L-aspartic acid,  a
transition  state analogue for this enzymatic reaction, has a 
powerful growth-inhibitory effect on  both  the  promastigote 
form and  on  the model screening  system for the  pathogenic 
amastigote form. This  inhibition by PALA’ is fairly compar- 
able with allopurinol that is undergoing clinical trial for 
visceral leishmaniasis at present (13). 
MATERIALS AND METHODS AND RESULTS’ 
Separation of Carbamyl Phosphate Synthetase, Aspartate 
Transcarbamylase and Dihydroorotase Activities-In crude 
The abbreviations used are: PALA, N-(phosphonacety1)-L-aspar- 
tic acid; DTT, dithiothreitol; PMSF, phenylmethylsulfonyl fluoride; 
ATCase, aspartate transcarbamylase; DHOase, dihydrorotase. 
Portions of this paper (including “Materials and Methods,” part 
of “Results,” Figs. S1-S6, and additional references) are presented in 
miniprint at the end of this paper. Miniprint is easily read with the 
aid of a  standard magnifying glass. Full size photocopies are included 
in the microfilm edition of the Journal that is available from Waverly 
Press. 
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extracts of L. donouani, carbamyl  phosphate  synthetase  activ- 
ity was found to be very unstable. The activity could be 
stabilized  for subsequent  operations only in  the presence of 
glycerol and dimethyl sulfoxide. In a  typical experiment, 
washed  pelleted  cell (3 g) was suspended in 3.0 ml of glass- 
distilled water  containing 1 mM DTT, 5 mM benzamidine,  0.1 
mM PMSF, 0.75 mg of soybean  trypsin  inhibitor  and allowed 
to swell for 15 min. 1.75 ml of dimethyl sulfoxide/glycerol 
mixture  (6:l) was added  to  the swelled cells and homogenized 
in a Potter-Elvehjem homogenizer. The  extract was adjusted 
to  50 mM Tris-HC1 buffer, pH 7.2, and centrifuged at  18,000 
X g for 30 min. One ml of the  supernatant was then applied 
on a Sephacryl S-200 column (57 X 1.25 cm), previously 
equilibrated  with 50 mM Tris-HC1 buffer, pH 7.5, 1 mM DTT, 
30% dimethyl sulfoxide, and 5% glycerol. The column was 
eluted also with 50 mM Tris-HC1 buffer containing 1 mM 
DTT, 30% dimethyl sulfoxide, and 5% glycerol at a flow rate 
of 6  ml/h. 
The elution profile is  shown  in Fig. 1. It is evident  that  the 
three  enzymatic  activities were separated  as  distinct  activity 
peaks on this column. In a separate experiment, using a 
partially purified  enzyme fraction, we could demonstrate  the 
separation of aspartate  transcarbamylase  and  dihydroorotase 
activities on a Sephadex G-100 column (see  Miniprint Sec- 
tion).  In  this case, however, we could not  detect  any  activity 
for carbamyl phosphate synthetase which was presumably 
lost  during processing. 
Purification and Characterization of Aspartate Transcar- 
bamylase-Results of a typical purification procedure are 
summarized  in  Table I. The approximate molecular  weight of 
the purified  homogenous protein was calculated  to be 135,000, 
and  analysis  under  denaturing  conditions showed it  to  consist 
of a  single subunit of molecular  weight 35,000. The enzyme 
failed to show any sigmoidal kinetics under a  variety of 
conditions  and was not significantly inhibited  or  activated by 
a large number of related metabolites.  PALA was found  to be 
a strong  inhibitor of pure  aspartate  transcarbamylase with  a 
K,  of 0.5 p ~ .  Experimental  details of these  results  are  pre- 
sented in the  Miniprint. 
Effect  of  PALA  on  Growth  of L. donouani  Promastigotes- 
DHOase ATCose 
\ I  I 
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FIG. 1. Profile of carbamyl phosphate synthetase, aspartate 
transcarbamylase, and dihydroorotase activities, eluted from 
Sephacryl S-200 column. The crude  extract  containing 12 mg of 
protein  in 1 ml of crude  extract was  applied to  a  column (57 X 1.25 
cm), previously equilibrated  with 50 mM Tris-HC1 buffer, pH 7.5, 1 
mM DTT, 30% dimethyl sulfoxide, 5% glycerol. Elution rate was 6 
ml/h  and 1.5-ml fractions were collected. Carbamyl  phosphate  syn- 
thetase,  aspartate  transcarbamylase,  and  dihydroorotase  activity  are 
represented by U, M, and A-A, respectively. The void 
volume is  indicated. 
TABLE I 
Purification of ATCase from L. donovani  promastigotes 
Step Total  Specific protein  activity  activity  Purification 
(i) Crude 
(ii) Protamine sulfate 
(iii) First ammonium 
sulfate  step 
(iv) Heat treatment 
(v) Second ammonium 
sulfate  step 
(vi) Sephadex G-100 
(vii) DEAE-cellulose 
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FIG. 2. Inhibition of growth of L. donouani in the presence 
of PALA. The control growth curve in the absence of PALA is 
represented by U. A-A, U, and o"-o indicate 
growth pattern  in  the presence of 40,  60, and 150 GM PALA, respec- 
tively. 
PALA has been  found to be a potent  inhibitor for growth of 
several mammalian cell lines  including transformed cells (14, 
15). PALA either alone or in combination with other anti- 
cancer drugs is undergoing  screening as a  possible anti-tumor 
agent (16, 17). In view of the  strong  inhibition of PALA on 
L. donouani aspartate transcarbamylase, its possible inhibi- 
tory effect on  the growth of L. donouani promastigotes was 
checked. Fig. 2 shows that PALA is a  fairly powerful inhibitor 
of growth for the organism, and the minimum inhibitory 
concentration was calculated to be approximately 60 PM. The 
50% effective dose is less than 20 PM (data  not shown) and is 
quite comparable in its effect with allopurinol and other 
pyrazolopyrimidine analogues that are being developed as 
possible chemotherapeutic  agents  against  the pathogenic  ki- 
netoplastida (13, 18). We could further demonstrate that 
addition of uracil or  uridine (100 PM) in  the growth medium 
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TABLE I1 
Effect  of  PALA and pentamidine  on  the  multiplication of L. donovani 
amastigotes  in  hamster  peritoneal macrophages in  vitro 
Experiment Arnastigotes/rnacrophage 
Inhibition Of 
(mean s.D.) amastigotes count/cell 
At 0 day 
At 3rd  day 
Infected control (untreated) 
Pentamidine 
PALA (25 pM) 
PALA (50 /.LM) 
Infected control (untreated) 
Pentamidine 
PALA (25 p M )  
PALA (50 MM) 
At 6th day 
% 
2.08 k 0.14 
5.01 k 0.22 
2.46 k 0.13" 51 
3.80 k 0.32" 24 
3.70 f 0.15" 26 
6.86 k 0.10 
1.70 k 0.20" 75 
3.43 f 0.18" 50 
3.36 k 0.04" 49 
" p  < 0.001 ( N  = 4). 
could substantially  protect the organism (nearly 50%) against 
inhibition by PALA (data  not shown). 
Effect of PALA on the Growth of the Pathogenic Form of L. 
donouani-PALA was found to have a definite inhibitory 
effect on the multiplication of the pathogenic or amastigote 
form, in the  in vitro macrophage assay system. This is evident 
from Table 11. PALA (30 p ~ )  could significantly retard the 
growth of Leishmania amastigotes when assayed in the ham- 
ster peritoneal macrophage system. The extent of inhibition 
observed with pentamidine which was used as the control 
drug agrees well with the recently reported value for this  drug 
in the same assay system (19). Increasing the concentration 
of PALA to 50 ~ L M  did not result in further inhibition of 
growth. 
DISCUSSION 
Resolution of carbamyl phosphate synthetase, aspartate 
transcarbamylase, and dihydroorotase activities on a  Sepha- 
cry1 S-200 column (Fig. 1) and of the  latter two activities on 
Sephadex G-100 column (Fig. S1, Miniprint) clearly show 
that  in L. donovani the  three enzymes are  not components of 
a multifunctional protein system. Partial separation of the 
three activities had earlier been achieved by density gradient 
technique in Toxoplasma glondi (11), a parasitic protozoa 
belonging to a different family. Apparently, in  all protozoal 
systems, the three enzymes are expressed as three distinct 
proteins,  and gene fusion for these activities may  have started 
at the level of yeast and Neurospora (1). Interestingly, a 
multifunctional protein system has recently been detected in 
Leishmania tropica (20,  21). In  this case, an overproduction 
of a bifunctional thymidylate synthetase-dihydrofolate reduc- 
tase  protein  takes place because of gene amplification when 
the organism is gradually exposed to higher concentrations of 
methotrexate. 
Leishmania aspartate  transcarbamylase is probably a tetra- 
mer of four identical subunits (Figs. S1B and S2, Miniprint). 
The enzyme failed to show any regulatory property or coop- 
erative kinetic phenomenon under a variety of conditions. 
Apparently, the flux of pyrimidine biosynthetic pathway is 
regulated at some other enzymatic step of this pathway. The 
quarternary structure of the enzyme, absence of a second 
subunit,  and general lack of sensitivity to nucleotides suggest 
some resemblance with the enzymes from  Streptococcus fae- 
calk or Bacillus subtilis (22). 
The moderately strong growth inhibitory property of PALA 
for both the vector (Fig. 2) and the host pathogenic form 
(Table 11) may be of some chemotherapeutic value. Consid- 
ering the extremely high affinity of PALA for leishmanial 
aspartate transcarbamylase, the  extent of inhibition or the 
concentration needed for complete inhibition of growth is not 
remarkable. Inefficient uptake of PALA to build up an effec- 
tive cellular concentration may  be a possible cause for this 
discrepancy. In  any case, when compared to allopurinol (18, 
23) which is already undergoing clinical trial with some suc- 
cess (24), the concentration of PALA to get the desired effects 
is fairly encouraging. In view  of these results, the possibility 
of combination therapy where the purine salvage pathway 
and  the de m u 0  pyrimidine pathway are simultaneously in- 
hibited should be explored. This is particularly relevant in 
the  context of increasing reports of resistance to the  treatment 
of pentavalent antimonials in the case of kala azar (24). 
Our present study with aspartate transcarbamylase from L. 
donouani indicates that sustained and intensive work on the 
enzymes of this pathway will  be useful in several directions. 
PALA can possibly be exploited as  a probe for studying the 
phenomenon of gene amplification and drug resistance as  it 
is being done in mammalian systems (25). Its potential as  a 
chemotherapeutic agent, either alone or in combination, after 
entrapment in liposomes or in suitable carriers should be 
further explored. In experimental models of leishmaniasis, 
passive targeting to liver macrophages of pentavalent  anti- 
monials encapsulated in liposomes has already shown consid- 
erable promise (26). Extensive knowledge on the regulatory 
and  other properties of the de novo pyrimidine pathway is 
expected to contribute significantly to  the comparative bio- 
chemistry of protozoal systems and  to development of new 
avenues for chemotherapy. 
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MATERIALS &.ND METHODS 
A 1 1  the biochemicals. unless otherwise mentioned were 
purchased from Slgma Chemical Co. U . S .  Pentamldlne was a rllft 
from Research Dlvision of May and Baker Co. PRLA was obtained 
a s  a generous glft from Dr. 6 .  R. stark then at Department of 
was obtained from New England  Nuclear. 
Blochemistry. Stanford University. L 14C]-NaHC03 (50 mci/mmoll 
a strain Obtalned from D 0 .  K. Gimsh of this Inrtltute. The 
organism was grown at 2'; on a solid blood-agar medium that has 
been descrlbed I" detail recently (11. The c e l l s  were maintained 
The orqanlsm used  for this work was L e l s h a n l a  donavani UR-6. 
scraped into phosphate saline buffer pH 1.2 11) .  washed  by 
centrlfugatlon and resuspended i n  the same buffer. 
smears (51. The effect of PALA on the amastigote vas examlned 
by following the growth of parasites i n  an vitro assay System 
based on hamster peritoneal macrophage culture follovlng the method 
developed by Chang and Dveyer (61. The macrophages were cultured 
On coverslips i n  4 m l  RPMI 1 6 4 0  medium supplemented vlth 10X heat 
Streppycin I100 p / m l l  
and penicillin 1100 U/mll for 4 8  hours 
inactivated fetal hovine serum, L-glutamlne I 4  MI. Hepes (25 mM1. 
at 37 C. The macr phage culture were then inoculated with 
arnastlgotes a t  a ratio of 5:1 and after lnoculatlon for 3 hours, 
the "on-phagocytized parasites were removed by washlng wlth medium. 
Fresh medium was added a lona  with drums. after 3 davs of incubation. 
medium including druq was replenished. At three and six days after 
treatment. the number of amastigotes per cell was determined 
according to the method of B e m a n  and  Wyler Ill. CoUntS of at 
least 100 infected macrophages were made ~n trlpllcate assays. 
and Kretchmer ( 8 1 .  The assay m l x t u r e  i n  0.5 m l  contaxned 2 5  p o l e  
Hepes-KOH buffer pH 1.6 5 ole L-glutamine 10 i°Fle spdtum bicarbonate. I2 x 10 CPMl and requlslte amount of ole Magnesium chlbrldpl0 p g l e  PotasLlum &?z:?d?' 
en yme to Inltlate the reaction. Aspartate transcartmylase was 
assayed colorimetrically, followlng essentially the method of 
Prescott and Jones (91. One m l  of lncvbatlon medlum contained 
50 p o l e  Tris-HC1 buffer pH 8.5, 5 6""'' carbamylphosphate. 
rea tlon was Started by addltxon of carbamyl phosghate fallowed by 
10 p o l e  of L-aspartate and the req lslte amount of enzyme. The 
terminated by addltian of 0.1 m l  of 10%. trichloroacetic acid. 
aspartate. After preincubation for 20 m l n 5  at 37 C the reac t ion  was 
After centrlfugatlon, carbamyl aspartate ~n the supernatant was 
estimated colorirnetr~cally followlng the method of Prescatt h 
Jnnes (9) a5 modlfied by Savage et a1.(101 one unlt of enzyme was 
deflned a s  the amount of en~yme @zd to generate 1 
according to the method of Kernpe et al. 1111. In thls case,  the 
carbamylaspartate per m l n  at 31 C. Dlhydroorotase E i Z a i E d  
fomatlon of carbamyl aspartate fromTihydrooratic acid was 
Jones 191. The Standard assay mlxture ~n 1 ml cantalned 100 
colorlmetrlcally estunated follovlng procedure of Preccott and 
TrlS-HCl buffer pH 8.8. 2.5 p o l e  L-dlhydroorotic acid  and ,&""le 
requsite amount of enzyme. The reactLon was Lnitiated with the 
s u b s t r a t e .  Lfter lncvbation of 20 mlns. a t  37 C the reaction was 
terninrted by addztlon of 1 rnl antipyrln-monoxlrne solution (2:ll 
and carbamyl aspartate formed vas measured a s  described above. 
Carbamyl phosphate syntktase *as assayed accardlng to Levine 
RESULTS 
PUrlflcatlOn of ATCase : A 1 1  operations u n l e s s  otherwise 
stated were carried out a t ~ i - 4 " ~ .  
The cells grovn on solld blood-agar medium for 6 6  hrs were 
=cr:?ped I" phosphate-iallne buffer and washed twice by 
centrlfugatlir. 
of 2 mM Hepes buffer pH 7 . 8  containing 1 mM EDTA. The swelled 
cells were homoglnlied ~n a Potter-Elvjhem homaginizer and another 
and 5 mM 2-marcaptoethanol. was added to it. The homogenate 
Was centrlfvged at 15.000 g for 30 m i n s  and the supernatant 
protamlne sulphate solutlon. was 110wiy added to the crude extract 
solutlon was designated as crude e x t r a c t  (95 d l .  11 lw/vl 
U n t i l  8% (v/vl wlth ContlnYous s t l r r l n g .  The precipltate waz  
removed by centrrfugatlon at 18,000 g for 30 mins (98 m l l .  
Packed cells 112 g )  were chilled and then swelled i n  4 8  m l  
4 8  ml Of a buffer mntalning 100 mM TRIS-HC1 p H  8.0. 1 mM EDTA 
wlth gent l e  sflrrlnq to a h t a m  approximately 151 ammon~um 
Sulphate Saturation. The preclpltate was discarded after 
was ralsed to 50% saturation by further addition of SOlld 
centrlfugatlon and the cancentratlo" of ammonium sulphate 
ammanlvrn sulphate (10.8 91. The precipitated protein. after 
centrlfugatlon was dissolved in 5 rnl of  Buffer A contalning 
50 mM T R l S - H C l  pH 8.0, 1 mM EDTA. and 2.5 mM 2-mercaptoethanol. 
Thls fraction was designated as the first ammonlum sulphate 
fraction. This fraction was heated to 60OC in a c ~ n s t a n t  
water bath for I mln and then irnmedlately chllled I" ice. 
The precipitated protein was removed by centrlfugat~on at 
18,000 g for 30 m n s  and the heat-treated clear supernatant 
1 5  mll Was further processed by addition of solld amnonium 
sulphate 11.76 g l  to 551 saturation. The precipltate obtalned 
after centrlfugatlon was redissolved in 1 ml of Buffer h .  
Solld ammonlum sulphate (20.48 g l  wag added to supernatant 
23. Marr, J. J., and Berens, R. L. (1977) J.  Infect. Dis. 136, 724-732 
24. Kager, P. A., Rees, P. H., Wellde, B. T., Hockmeyer, W. T., and 
Lyerly, W. H. (1981) Trans. R. SOC. Trop.  Med.  Hyg. 75, 556- 
559 
25. Wahl, G. M., Padgett, R. A., and Stark, G. R. (1979) J.  Biol. 
Chem. 254,8679-8689 
26. Pozansky, M. F., and Juliano, R. L. (1984) Pharmacol. Rev. 36, 
Additional references are found below. 
277-336 
3 w e e k s  
polyacrylamide gel electropharesls of  the enzyme fraction after 
the flnal purification step revealed a single band  of p r o t e i n  
(Fig. 1AI. The approximate molecular welght of the purified 
ernyme was determined to be 1 . 3 5 . 0 0 0  on a calibrated 
dodecyl-sulphate~polyacrylamlde gel  electrophoresis in presence 
Sephadex 6.200 column u s i n g  markpr protelns ( F i g .  21. Sodium- 
of 2 -mercaptoethanol was carrled out according to the procedure 
of L a e m l l  (12) and this revealed the presence of one single 
molecular velght vas calculated to be 35,000 uslng marker 
polypeptide band far the enzyme (Fig. 161. Approximate 
protelns I F l g .  31. 
!4*(olecular uelqht and subunit structure of the enzyme: The 
Kinetlc propertlee of the enzyme: ~TCase exhlblted 
strlctly hyperbolic klnetlcs both with aspartate (Fig. 41 and 
wlth carhamylphosphate (Fig. 51 as substrates. The Km for 
aspartate and for carbamylphosphate were calculated to be 
7 . 6  mM and 0 . 3 1  mM respectlvely. Slnce the purification 
procedure Involved a heat-step and this often results ~n 
desensltirarlon of potentlal allosteric sites, the klnetlcs 
yith both the substrates were carried out n t h  the partially 
purlfred dyalyred enzyme before the heat-step was mtroduced. 
low concentrations of elther Of the Substrate (data not 
In th15 case also no slmnoldal kinetics could be observed at 
shown). The Optmum pH Of the enzyme was determined to be 
8.6. 
A laroe number Of nucleotides. mono, di and triphosphates 
were tested for thelr potentlal modulatory role on the kinetic 
properties of the enzyme. Amongst all the compounds tested 
only ATP 13 mM1 showed a moderate Inhibitla" of 25% with 8 mM 
asuartate and 0.5 mN carbamylphosphate a s  substrates. Lowerlnq 
Stark I131 a s  a tlansitlon state analogue for E.co11 ATCaSe 
that powerfully inhibited I ~ S  actlvlty. PALA w a x u n d  to be 
a very potent lnhlbltor for aspartate transcarbamylase from 
kelshmanra donovani promastlgates. Klnetlc analysis Showed 
carbamylphosphate as varying substrate with X i  Of 0.5 UM 
that  it a c t s t r i c t l y  competltlve mhibltar with 
I F l g .  5 1 .  In Contrast, PALA was found to be a strlct4y non- 
CompetltLve lnhlbltor when aspartate was used as the v a r y i n g  
Inhlbltlon by PALA : PALA was Introduced by C o l l l n s  and 
substrate (F1g. 4 1 .  
Separatlon of A T C a s e  and DHOase activltles: C e l l s  were 
suspended in 10 rnl of phosphate-saline buffer wlth protease 
mhlbltor ( 0 . 2 5  rng/rnll. The cells were transferred to a 
Inhlbltors. benramldine ( 2 . 5  mM1 and soyabean trypsin 
centrrfuge tube and pelleted by splnnlng for 5 mrns at 3000 g .  
Same procedure vas repeated agaln.  The packed cell pellet 
13 41 was resuspended i n  12 m l  of hypotonLC buffer containing 
5 mM sodlumphosphate buffer pH 7 . 4 .  2 mM MgCl  2 mM CaCl 
1 mM DTT, 2.5 mM benrmldine. 0 . 1  mM PMSF, 0.2; m g h l  soyabean 
trypsin Inhlbltor. The cells were allowed to swell for 1 0  mlns 
prlor to lysls i n  potter Elv2hem hamogenrzer. After homogenl- 
was added to the lysate. It was centrifuged at 18.000 g 
zatlon another 12 m l  of 200  mM sodimphasphate buffer pH 7 . 4  
for 30 mins. The supernatant solution was deslgnated as crude 
extract 123 m l l .  Protamine sulphate and ammonlum sulphate 
ATCISB descrlbed earller. Length of tlme between c e l l  lysis 
steps were carrled out according to purlflcatlon procedure of 
and ammomum sulphate preclpitation was reduced to a s  minlmvm 
a s  possible. The c e l l  pellet (from 35 to 5 0 %  m o n l u m  sulphate 
sa tur -a t~on l  was redlseolved ~n I m l  of buffer B contalning 50 mM 
Na-phosphate buffer pH 7 . 4   0 . 6  DTT 25 UH ZnS04. Thls 
solutlon was passed through a colum; of dephadex 6-100 1 1 . 5  crn x 
pattern 1s Shown I" Flg. 6 .  
61 m i .  previously equillbrated with buffer 8 .  The elution 
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Figs. I A  b l B  : 
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Fig. 2 : Determination of molecular velqht O f  AXase  by qel 
filtration on a calibrated sephadcx G-200 column: 
' v  ' is the elution volume of protein and 'V,,' Is 
ths void volume of the column. 
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Fig. 1 : Effect ot L-aspartate on inhibition of A'TCase by PALA: 
and  Methods Section. Requisite mount of the 
Enzyme activity was assayed a s  described in Materials 
purlfled enzyme was used per assay with fixed 
concentration of carbamyl phsophate I1 m N 1 .  The 
concentration of PALA CI. zero: w . o . 0 1  m: -. 0 . 0 2  mN. 
L.01- 
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Fig. 6 : Profile Of ATCase, DHOase activitles and protein 
eluted from Sephadex G-100 column: The ammonium 
sulphate  preclpltate containing 22 rng of protein 
~n 1 m l  of buffer B was applled to a column 
fractions were collected.  Protein content, 
(1.5 x 6 1 ) o n .  Elutlon rate was 5 nl/hr and 1 rnl 
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ATCa5e aCtlYiry and D H O a s e  actlvity  are  represented 
by , &-A , - , respectively. 
